398 related articles for article (PubMed ID: 26699090)
1. Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
Emiralioglu N; Dogru D; Tugcu GD; Yalcin E; Kiper N; Ozcelik U
Ann Pharmacother; 2016 Mar; 50(3):188-93. PubMed ID: 26699090
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
3. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
[TBL] [Abstract][Full Text] [Related]
4. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.
Nepomuceno IB; Esrig S; Moss RB
Chest; 1999 Feb; 115(2):364-70. PubMed ID: 10027433
[TBL] [Abstract][Full Text] [Related]
5. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
[TBL] [Abstract][Full Text] [Related]
6. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
Tanou K; Zintzaras E; Kaditis AG
Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
[TBL] [Abstract][Full Text] [Related]
8. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Lehmann S; Pfannenstiel C; Friedrichs F; Kröger K; Wagner N; Tenbrock K
Ther Adv Respir Dis; 2014 Oct; 8(5):141-9. PubMed ID: 25150265
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Skov M; Høiby N; Koch C
Allergy; 2002 Aug; 57(8):723-8. PubMed ID: 12121192
[TBL] [Abstract][Full Text] [Related]
11. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
[TBL] [Abstract][Full Text] [Related]
12. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Omalizumab in Patients with Allergic Bronchopulmonary Aspergillosis Complicated by Chronic Bacterial Infection in the Airways.
Tomomatsu K; Oguma T; Baba T; Toyoshima M; Komase Y; Taniguchi M; Asano K;
Int Arch Allergy Immunol; 2020; 181(7):499-506. PubMed ID: 32388510
[TBL] [Abstract][Full Text] [Related]
14. Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis.
Epps QJ; Epps KL; Zobell JT; Young DC
Pediatr Pulmonol; 2020 Dec; 55(12):3541-3572. PubMed ID: 32946194
[TBL] [Abstract][Full Text] [Related]
15. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.
Zirbes JM; Milla CE
Pediatr Pulmonol; 2008 Jun; 43(6):607-10. PubMed ID: 18433040
[TBL] [Abstract][Full Text] [Related]
16. Allergic bronchopulmonary aspergillosis in children.
Manti S; Parisi GF; Papale M; Licari A; Chiappini E; Mulè E; Rotolo N; Leonardi S
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():20-22. PubMed ID: 33236425
[TBL] [Abstract][Full Text] [Related]
17. Allergic bronchopulmonary aspergillosis in two patients with cystic fibrosis.
Anadol D; Ozçelik U; Kiper N; Göçmen A
Turk J Pediatr; 2000; 42(1):68-71. PubMed ID: 10731875
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD010288. PubMed ID: 34550603
[TBL] [Abstract][Full Text] [Related]
19. Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis.
Gothe F; Schmautz A; Häusler K; Tran NB; Kappler M; Griese M
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2608-2614.e3. PubMed ID: 32147521
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis.
Koutsokera A; Corriveau S; Sykes J; Coriati A; Cortes D; Vadas P; Chaparro C; McIntyre K; Tullis E; Stephenson AL
J Cyst Fibros; 2020 Jan; 19(1):119-124. PubMed ID: 31405730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
